Stock listing

Frankfurt:L8S Grace Therapeutics, Inc. Aktie

German listing (Frankfurt) of Grace Therapeutics, Inc. · home listing NASDAQ:GRCE

Follow Grace Therapeutics, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:GRCE

$1.98 USD +0.10 (+5.3%)

Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:GRCE

Past 3 months -21.7% · daily closes, Jul 6, 2026 – Oct 20, 2026, adjusted for splits
Day range
$1.89 – $2.07 USDOct 20, 2026
Volume
94,370 sharesOct 20, 2026
Market cap
$41.65M USDAt the close on Oct 20, 2026 · price × 21.04M shares outstanding
Grace Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:GRCE · Home$1.98 USD+0.10 (+5.3%)94,370$1.90$2.07$1.89$1.88Close on Oct 20, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:GRCE · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.98+0.10+5.3%$1.90$2.07$1.8994,370
$1.88-0.01-0.5%$1.89$1.97$1.82290,430
$1.89-0.06-3.1%$1.87$2.031$1.85168,652
$1.95+0.06+3.2%$1.91$1.97$1.89109,289
$1.89-0.10-5.0%$1.97$2.01$1.846177,832
$1.99-0.03-1.5%$2.00$2.02$1.96549,222
$2.02-0.06-2.9%$2.02$2.06$1.9849,253
$2.08+0.04+2.0%$2.05$2.09$2.0337,794
$2.04-0.06-2.9%$2.05$2.07$2.0052,592
$2.10+0.03+1.4%$2.06$2.12$2.0584,252
$2.07+0.01+0.5%$2.08$2.14$2.05110,300
$2.06-0.01-0.5%$2.04$2.08$2.0179,000
$2.07+0.03+1.5%$2.04$2.07$2.00105,000
$2.04-0.11-5.1%$2.11$2.13$1.98344,200
$2.15+0.04+1.9%$2.14$2.16$2.1025,300
$2.11-0.01-0.5%$2.11$2.15$2.09130,200
$2.120.000.0%$2.12$2.14$2.0958,700
$2.12-0.04-1.9%$2.14$2.14$2.1080,200
$2.16+0.04+1.9%$2.17$2.18$2.09106,300
$2.12-0.02-0.9%$2.15$2.15$2.09184,700
$2.14+0.04+1.9%$2.09$2.17$2.0870,100
$2.10-0.01-0.5%$2.12$2.15$2.08109,900
$2.11-0.02-0.9%$2.14$2.17$2.1083,700
$2.13-0.01-0.5%$2.25$2.25$2.1272,200
$2.14-0.09-4.0%$2.23$2.24$2.1465,500
$2.23-0.06-2.6%$2.29$2.29$2.1766,200
$2.29+0.07+3.2%$2.21$2.32$2.2148,300
$2.22-0.04-1.8%$2.29$2.46$2.20716,000
$2.26+0.12+5.6%$2.24$2.31$2.20397,500
$2.14+0.02+0.9%$2.12$2.15$2.07224,700
$2.12+0.02+1.0%$2.09$2.14$2.05159,500
$2.10-0.04-1.9%$2.12$2.19$2.08186,300
$2.140.000.0%$2.15$2.20$2.07159,200
$2.14+0.04+1.9%$2.19$2.19$2.1049,000
$2.10-0.03-1.4%$2.09$2.14$2.0777,700
$2.13+0.01+0.5%$2.10$2.14$2.07117,300
$2.12-0.04-1.9%$2.16$2.16$2.1266,100
$2.16+0.01+0.5%$2.10$2.18$2.1082,300
$2.15-0.05-2.3%$2.20$2.20$2.1422,200
$2.20+0.02+0.9%$2.18$2.22$2.1894,443
$2.18-0.02-0.9%$2.23$2.23$2.1386,601
$2.20+0.06+2.8%$2.15$2.23$2.1575,900
$2.14-0.06-2.7%$2.19$2.24$2.1054,700
$2.20+0.07+3.3%$2.16$2.21$2.15159,800
$2.13-0.03-1.4%$2.17$2.17$2.04103,900
$2.160.000.0%$2.19$2.25$2.1599,400
$2.16+0.09+4.3%$2.06$2.19$2.02397,800
$2.07-0.03-1.4%$2.10$2.13$2.06193,800
$2.10-0.02-0.9%$2.13$2.13$2.06121,800
$2.12+0.01+0.5%$2.10$2.13$2.0897,800
$2.11-0.02-0.9%$2.13$2.16$2.08184,300
$2.13+0.01+0.5%$2.13$2.16$2.10120,400
$2.12-0.02-0.9%$2.14$2.25$2.08162,700
$2.14-0.04-1.8%$2.19$2.23$2.08649,100
$2.18+0.10+4.8%$2.09$2.18$2.07100,500
$2.080.000.0%$2.13$2.14$2.0896,000
$2.08+0.01+0.5%$2.10$2.17$2.03177,500
$2.07-0.01-0.5%$2.04$2.08$1.95296,900
$2.08-0.17-7.6%$2.20$2.25$1.851,356,600
$2.25-0.05-2.2%$2.38$2.38$2.14517,900
$2.30-0.03-1.3%$2.30$2.44$2.28116,100
$2.33-0.02-0.9%$2.35$2.36$2.29127,100
$2.35-0.02-0.8%$2.36$2.39$2.35101,700
$2.37-0.06-2.5%$2.40$2.43$2.36104,000
$2.430.000.0%$2.43$2.48$2.4194,300
$2.43-0.04-1.6%$2.44$2.48$2.39104,800
Ticker
Frankfurt:L8S
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Acasti Pharma, Inc. (ACST) Q3 2023 Earnings Call

    Tue, Feb 14, 2023 · 1:00 PM ET

    Watch Transcript
  • Acasti Pharma, Inc. (ACST) Q2 2023 Earnings Call

    Mon, Nov 14, 2022 · 1:00 PM ET

    Watch Transcript
  • Acasti Pharma, Inc. (ACST) Q1 2023 Earnings Call

    Thu, Aug 11, 2022 · 1:00 PM ET

    Watch Transcript

Latest news

All Grace Therapeutics, Inc. news

Financings

  • Private placement of private placement financing

    Aug 13, 2026

    Update: about US$10M · US$2.1 a share · Craig-Hallum

    Dealers: Craig-Hallum (lead)

    Use of proceeds: Support the manufacturing and regulatory work needed to advance GTx-104

    Announced Aug 5, 2026 · Update Aug 13, 2026

Read by 6ix AI from the company's releases

Decks

Grace Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
14 in the last 12 months · 29 in all · newest Sep 3, 2026 · oldest 2024
Calls
6 calls with a replay · 6 with a transcript · latest Feb 14, 2023
Decks
10 decks · latest Jul 28, 2026

Where Grace Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:GRCE · Home listingNASDAQUnited StatesUSD
BOATS:GRCEBOATSUnited StatesUSD
Lang & Schwarz:A40LELLang & SchwarzGermanyEUR
Frankfurt:L8S · This pageFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Grace Therapeutics, Inc.